We sit down with you and build your perfect lead list. Book a call with founders.

Alloyed Analysis

What is Alloyed?

Proprietary ABD® alloy design platform for extreme environment metal components
Location
Yarnton, United Kingdom
Employees
51-200
Founded
2017

Product Features & Capabilities

  • ABD® alloy design platform for additive manufacturing
  • ABD®-900AM nickel alloy for AM
  • ABD®-1000AM world's highest temperature AM nickel alloy
  • Inoveo cast platinum alloy
  • Custom alloy development for extreme environments
  • Rapid mechanical testing
  • Process simulation
  • Computational alloy development

Use Cases

Design nickel alloys for extreme temperature environments; Develop cast platinum alloys for jewellery market; Create biomedical implants for medical applications; Produce aerospace flight parts with AS9100 certification; Optimize metal components for additive manufacturing; Conduct rapid mechanical testing on custom alloys

Other Considerations

Achieved AS9100 aerospace certification in Seattle; First biomedical implant certified and produced; Strategic partnership with Boeing; Licensing agreements with Hitachi Metals, Aubert & Duval, and NTT Data XAM; Production site opened in Seattle; ABD®-1000AM recognized as world's highest temperature AM nickel alloy; Production site in Abingdon Foxcombe; Series B funding in 2024; Founded in 2017 as OxMet Technologies; Pre-seed funding in 2017; Series A funding in 2020 led by JX and Oxford Science Enterprise; Series A extension in 2021 led by Anglo and Oxford Science Enterprise; Merger with Betatype in 2020 to become Alloyed; First licensing transaction with Hitachi Metals in 2017/2018; Invention of ABD®-900AM in 2017/2018; Invention of ABD®-1000AM in 2024; Invention of Inoveo alloy in 2020; Partnership with Anglo American in 2019 for platinum alloys; Production of first biomedical implant in 2021; Opening of Seattle production site in 2022; Opening of Abingdon Foxcombe site in 2022; Strategic partnership with Boeing in 2023; First flight parts sold in Seattle in 2023; Series B funding in 2024